Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

The value of post-therapy F-18 FDG PET/CT surveillance scans in the detection of recurrent nasopharyngeal carcinoma

Khun Visith Keu, Erik Mittra, Andrew Quon and Andrei Iagaru
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 510;
Khun Visith Keu
1Stanford University, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Mittra
1Stanford University, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Quon
1Stanford University, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Iagaru
1Stanford University, Stanford, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

510

Objectives The role and the frequency of post-therapy surveillance F-18 FDG PET/CT for detecting nasopharyngeal carcinoma (NPC) recurrence are undefined. We analyzed the impact of surveillance scans on outcome at different intervals.

Methods This is a retrospective review of 103 patients with NPC who were referred for post-treatment F-18 FDG PET/CT at our institution. Participants who had a complete metabolic response (CMR) on the early post-therapy scan (within 3 months of the last chemo-radiotherapy cycle) and a minimum of 12 months clinical follow-up were eligible. Recurrence was established with imaging, clinical and/or histological findings. Follow-up PET/CT scans were assessed at different intervals only if preceding scans were negative. Demographics, imaging and pathologic features were described using student T-test, Chi-Square and Kruskal-Wallis as appropriate.

Results A total of 44 patients (mean age ± SD: 44 ± 13 year-old) fit the entry criteria from July 2002 to October 2009. 66% were men, 80% were Asian, 64% were nondrinker, 34% were current/past smokers, and 82% had undifferentiated type (WHO 3 category) on histology. Eight patients had stage I-II NPC (18%) compared to stages III (41%) and IV (41%). Thirty-one patients were disease-free at the time of analysis (group A) and 13 patients had recurrence on follow-up scans (group B). There was no statistically significant difference between the median SUVmax of the primary lesion on the early post-treatment scans in the group who had recurrent disease vs. the group who did not (4.5 vs. 3.7, P=0.10). The detection rates of recurrence were 16% (4 of 38 scans) after 3-12 months post-therapy, 21% (8 of 28) at 13-24 months, 0% (0 of 12) after 25-36 months and 11% (1 of 9) after 37 months.

Conclusions NPC patients who achieved a CMR on the immediate post-treatment F-18 FDG PET/CT seem to benefit from regular surveillance scans up to 24 months. Delayed surveillance scans (>24 months) may not be necessary in patients who already had negative post-treatment scans, thus avoiding additional healthcare costs and radiation.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The value of post-therapy F-18 FDG PET/CT surveillance scans in the detection of recurrent nasopharyngeal carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The value of post-therapy F-18 FDG PET/CT surveillance scans in the detection of recurrent nasopharyngeal carcinoma
Khun Visith Keu, Erik Mittra, Andrew Quon, Andrei Iagaru
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 510;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The value of post-therapy F-18 FDG PET/CT surveillance scans in the detection of recurrent nasopharyngeal carcinoma
Khun Visith Keu, Erik Mittra, Andrew Quon, Andrei Iagaru
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 510;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • PET/CT as a predictor of malignancy in indeterminate lung nodules
  • Mismatch between intratumoral blood perfusion and glucose metabolism in same patients with cancer by 18FDG PET/CT scans: A Pilot human study
  • Diagnosis value of trimoality PET/CT-MR in digestive tract disease
Show more Oncology: Clinical Diagnosis

Head & Neck II

  • Comparison of false negative rates (FNR) & overall accuracy (AC) of sentinel lymph node biopsy (SLNB) in phase 3 99mTc-tilmanocept (TcTM) vs ACOSOG Z-0360 99mTc-sulfur colloid (TcSC) in head/neck squamous cell cancer (SCC)
  • Comparison of prognostic value of tumor SUL-peak and SUV-max on pretreatment FDG-PET/CT in patients with HNSCC
  • Comparison of contrast enhanced PET/MRI and contrast enhanced PET/CT in patients with head and neck cancer
Show more Head & Neck II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire